The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2024

Filed:

Aug. 26, 2020
Applicants:

Anas El Fathi, Lasalle, CA;

Ahmad Haidar, Montreal, CA;

Robert Edward Kearney, Montreal, CA;

Inventors:

Anas El Fathi, Lasalle, CA;

Ahmad Haidar, Montreal, CA;

Robert Edward Kearney, Montreal, CA;

Assignee:

Other;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); A61M 2205/3303 (2013.01); A61M 2205/50 (2013.01); A61M 2230/201 (2013.01);
Abstract

There is provided a method and a system for determining recommended multiple daily injections (MDI) therapy values for administering to a given subject. Consumed meals, insulin basal doses administered and insulin bolus doses administered to the given subject are received. An initial meal ratio parameter and an initial basal insulin dose used by the given subject are received. A predicted glucose concentration parameter is determined based on the consumed meals, the insulin basal dose, the insulin bolus doses, and the initial meal ratio parameter. An actual glucose concentration parameter is received. A set of optimal MDI therapy parameters are estimated using the predicted glucose concentration parameter, and the actual glucose concentration parameter. A set of optimal MDI therapy parameters are determined based on the current MDI therapy parameters, the set of recommended MDI therapy parameters comprising an optimal meal ratio parameter, and an optimal basal insulin dose to be administered to the given subject.


Find Patent Forward Citations

Loading…